Clinical Report on collagen
Genacol is Collagen Type II
For Subjective Pain Relief
March 1999:
Pain syndromes are a part of many people's daily lives. It can render them disabled insome manner or it can be a degenerative chronic residual from trauma or disease processes.Our objective was to analyze the effectiveness of Collagen Type II versus placebotreatment on these people, and report the results and measure the response by the subject.
? - Drs. K. Buckman, J. Gutierrez; et al
AUTHORS
? - To compare the effects of placebo versus Collagen Type II on the courseof pain syndromes.
OBJECTIVE
? - Made of capsules containing standard ingredients of no nutritional orsynthetic value.
Placebo
? - Each treatment of 4 capsules containing 400 mg. of Collagen typeII.
Collagen Type II
Collagen Type II naturally contains 15% of Glucosamine Sulfate and 15% of ChondroitinSulfate.
RESEARCH DESIGN AND METHODS
We entered 89 random subjects with various types of pain syndromes. All subjects wereinterviewed and asked to describe their subjective pain and where their pain was located.They were also asked if they had been given a new prescription or any changes on theircurrent medical regiment. If there were changes in the subjects regiment, that subject wasnot included in the study. Each subject was told the program would last three months.
The subjects were asked to follow the directions on the bottle:
1. Take 4 capsules of the Collagen Type II in the morning with orange juice
2. Take twenty to thirty minutes before they ate breakfast
3. Record what day they responded to treatment
The following descriptions of pain were given by the subjects
?
- Rheumatoid Arthritic Pain
- Osteoarthritis Joint Pain
- Post Surgical Joint Pain
- Post Traumatic Pain
- Fibrositis
- Gouty Arthritis
- Lumbosacral Pain with/without radicular pain
- Cervical Spine Pain with/without radicular pain
?89.9% of the subjectsreceived pain relief at some level within 45 days of taking the Collagen Type II capsules.?
?
RESULTS
COMPLIANCE
All subjects were compliant with taking four capsules a day. After end trial interviews wefound that 9% of the subjects took more than four, but less than seven capsules a day.
??
?
Table 1. Results of response to pain relief by (X) days:
?
DAYS TO RESPONSE | 0-7 DAYS | 8-21 DAYS | 21-45 DAYS | TOTALS |
Rheumatory Arthritis | 9 | 6 | 3 | 18 |
Osteoarthritis | 7 | 12 | 5 | 24 |
Fibrosis | 4 | 7 | 2 | 13 |
Lumbosacral w/ history of herniated disc | 3 | 6 | 3 | 12 |
Chronic Post Traumatic Pain | 2 | 4 | 3 | 9 |
Gouty Arthritis | 2 | ? | ? | 2 |
Cervical Spine w/ history of herniated disc | ? | 1 | 1 | 2 |
Placebo | ? | ? | (1) | (1) |
Non responsive | ? | ? | 9 | 9 |
Totals | 27 | 36 | 26 | 89 |
??
? of the trial. Many of these pained subjects had previouslybeen on long term, pharmaceutical treatment programs.
The total without a response of less pain in 45 days was nine or approximately 10.1%and only (one) placebo subject recorded a response in 45 days.
SIDE EFFECTS
Only one subject had nausea. It was noted that he was on other medications as well.
CONCLUSION
Collagen Type II treatment had a significant effect on subjective pain syndromes. Most subjects responded to Collagen Type II in thefirst 21 days
Many subjects responded by initiating life style changes due to lack of pain. Many wereexcited by the increase in their daily activity. The results have prompted the authors todevelop specific disease/pain syndrome trials in the near future.
?
Dr. C. Searling, Fresco, CA
"The results wereoverwhelmingly positive for pain relief
and the side benefits were remarkable!
This product has changed my life significantly."
Reference?: Internet